$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000110465914034090 Filed on May 02, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q4
Revenue	$0.00	$294.0K	$1.036M
YoY Change	-100.0%	-71.62%	0.0%
Cost Of Revenue
YoY Change
Gross Profit			$1.036M
YoY Change			0.0%
Gross Profit Margin			100.0%
Selling, General & Admin	$12.40M	$9.042M	$6.589M
YoY Change	78.93%	105.17%	42.03%
% of Gross Profit			636.0%
Research & Development	$7.200M	$7.430M	$6.713M
YoY Change	11.51%	-1.28%	-35.69%
% of Gross Profit			647.97%
Depreciation & Amortization	$600.0K	$656.0K	$400.0K
YoY Change	100.0%	108.92%	33.33%
% of Gross Profit			38.61%
Operating Expenses	$19.60M	$16.47M	$13.30M
YoY Change	46.41%	38.04%	-11.78%
Operating Profit		-$16.18M	-$12.27M
YoY Change		48.46%	-12.65%
Interest Expense	$100.0K	$100.0K	$16.00K
YoY Change	455.56%	426.32%	-20.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$19.40M	-$16.10M	-$12.20M
YoY Change	57.72%	47.71%	-12.86%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$19.40M	-$16.10M	-$12.20M
YoY Change	57.72%	47.71%	-12.86%
Net Earnings / Revenue		-5476.19%	-1177.61%
Basic Earnings Per Share
Diluted Earnings Per Share	-$236.6K	-$226.8K	-$172.3K
COMMON SHARES
Basic Shares Outstanding	82.81M shares	71.20M shares	70.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$234.8M	$116.0M	$133.3M
YoY Change	48.89%	21.47%	23.31%
Cash & Equivalents	$20.70M	$17.81M	$12.85M
Short-Term Investments	$214.1M	$98.20M	$120.4M
Other Short-Term Assets	$4.000M	$2.800M	$2.200M
YoY Change	263.64%	154.55%	266.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$238.8M	$118.9M	$135.5M
YoY Change	50.36%	23.1%	24.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.00M	$15.28M	$11.17M
YoY Change	286.89%	343.81%	228.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$17.00M	$15.28M	$11.17M
YoY Change	286.89%	343.81%	228.02%
TOTAL ASSETS
Total Short-Term Assets	$238.8M	$118.9M	$135.5M
Total Long-Term Assets	$17.00M	$15.28M	$11.17M
Total Assets	$255.8M	$134.1M	$146.6M
YoY Change	56.73%	34.14%	30.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$400.0K	$1.331M	$761.0K
YoY Change	-63.1%	-36.04%	-79.16%
Accrued Expenses	$8.600M	$6.806M	$5.806M
YoY Change	103.45%	103.47%	74.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$400.0K	$400.0K
YoY Change	33.33%	33.33%	33.33%
Total Short-Term Liabilities	$9.800M	$9.033M	$7.752M
YoY Change	22.21%	-1.44%	-32.33%
LONG-TERM LIABILITIES
Long-Term Debt	$1.200M	$1.000M	$1.000M
YoY Change	20.0%	0.0%	0.0%
Other Long-Term Liabilities	$1.900M	$2.100M	$2.200M
YoY Change	1800.0%	2000.0%	450.0%
Total Long-Term Liabilities	$3.100M	$1.000M	$1.000M
YoY Change	210.0%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.800M	$9.033M	$7.752M
Total Long-Term Liabilities	$3.100M	$1.000M	$1.000M
Total Liabilities	$12.90M	$10.03M	$8.752M
YoY Change	43.03%	-1.3%	-29.73%
SHAREHOLDERS EQUITY
Retained Earnings		-$336.9M	-$320.8M
YoY Change		18.16%	16.96%
Common Stock		$458.5M	$456.0M
YoY Change		22.54%	22.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$242.9M	$121.8M	$135.3M
YoY Change
Total Liabilities & Shareholders Equity	$255.8M	$134.1M	$146.6M
YoY Change	56.73%	34.14%	30.78%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q4
OPERATING ACTIVITIES
Net Income	-$19.40M	-$16.10M	-$12.20M
YoY Change	57.72%	47.71%	-12.86%
Depreciation, Depletion And Amortization	$600.0K	$656.0K	$400.0K
YoY Change	100.0%	108.92%	33.33%
Cash From Operating Activities	-$16.50M	-$12.40M	-$10.30M
YoY Change	66.67%	2.48%	-0.96%
INVESTING ACTIVITIES
Capital Expenditures	-$2.400M	$4.763M	-$4.300M
YoY Change	84.62%	1166.76%	4200.0%
Acquisitions
YoY Change
Other Investing Activities	-$116.2M	$22.10M	$17.60M
YoY Change	137.14%	206.94%	60.0%
Cash From Investing Activities	-$118.6M	$17.30M	$13.20M
YoY Change	135.79%	154.41%	21.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	138.0M	0.000	300.0K
YoY Change	87.5%		50.0%
NET CHANGE
Cash From Operating Activities	-16.50M	-12.40M	-10.30M
Cash From Investing Activities	-118.6M	17.30M	13.20M
Cash From Financing Activities	138.0M	0.000	300.0K
Net Change In Cash	2.900M	4.900M	3.200M
YoY Change	-78.36%	-192.45%	357.14%
FREE CASH FLOW
Cash From Operating Activities	-$16.50M	-$12.40M	-$10.30M
Capital Expenditures	-$2.400M	$4.763M	-$4.300M
Free Cash Flow	-$14.10M	-$17.16M	-$6.000M
YoY Change	63.95%	37.57%	-41.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q2	exas	Vesting Rights Number Of Annual Installments VestingRightsNumberOfAnnualInstallments	3	item
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	EXACT SCIENCES CORP
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001124140
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2013Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1217000	USD
CY2014Q1	exas	Number Of Stages Of Software Development NumberOfStagesOfSoftwareDevelopment	3	item
CY2014Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	98204000	USD
CY2014Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 20.15pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</font></p> </div>
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7695000	shares
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7984000	shares
CY2014Q1	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	80000	shares
CY2014Q1	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
CY2013Q1	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	165000	shares
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2014Q1	exas	Minimum Contractual Term Of Certain Current Investments Which Can Be Liquidated MinimumContractualTermOfCertainCurrentInvestmentsWhichCanBeLiquidated	P1Y
CY2014Q1	exas	Number Of Objectives Of Entitys Investment Strategy NumberOfObjectivesOfEntitysInvestmentStrategy	2	objective
CY2014Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	120283000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	120408000	USD
CY2013Q4	exas	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	125000	USD
CY2014Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	98071000	USD
CY2014Q1	exas	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	133000	USD
CY2014Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	98204000	USD
CY2013Q1	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q4	us-gaap	Assets Current AssetsCurrent	135458000	USD
CY2013Q4	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	5087000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2199000	USD
CY2014Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1218000	USD
CY2014Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5050000	USD
CY2014Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	268000	USD
CY2014Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3694000	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1331000	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6806000	USD
CY2014Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	356000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18970000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15276000	USD
CY2014Q1	us-gaap	Assets Assets	134128000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9033000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	121756000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	134128000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12851000	USD
CY2013Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	120408000	USD
CY2013Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2592000	USD
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82814518	shares
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2000000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1000000	USD
CY2014Q1	exas	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.0499	pure
CY2013Q1	exas	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.0276	pure
CY2013Q1	us-gaap	Depreciation Depreciation	314000	USD
CY2014Q1	us-gaap	Share Price SharePrice	14.17
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	20600000	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y22D
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1800	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	7200	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	67853000	USD
CY2014Q1	exas	Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost	30218000	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	98071000	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	67918000	USD
CY2014Q1	exas	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	30286000	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2842000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	118852000	USD
CY2014Q1	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	7508000	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5043000	USD
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	268000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14207000	USD
CY2014Q1	us-gaap	Lease Incentive Payable Current LeaseIncentivePayableCurrent	540000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3038000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11169000	USD
CY2013Q4	us-gaap	Assets Assets	146627000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	761000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5806000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	351000	USD
CY2013Q4	us-gaap	Lease Incentive Payable Current LeaseIncentivePayableCurrent	540000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	294000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7752000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2013Q4	exas	Interest Payable Noncurrent InterestPayableNoncurrent	84000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	360000	USD
CY2013Q4	exas	Lease Incentive Payable Noncurrent LeaseIncentivePayableNoncurrent	2115000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	711000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	455239000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320759000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	135316000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	146627000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71071838	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71071838	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71262715	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71262715	shares
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-7000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10861000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16099000	USD
CY2013Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-25000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	16472000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16178000	USD
CY2014Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	955000	USD
CY2013Q1	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-1036000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16107000	USD
CY2013Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	140000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	474000	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1456000	USD
CY2013Q1	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7526000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2648000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1759000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	11933000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10897000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	62000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	19000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10854000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63836000	shares
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1571000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	372000	USD
CY2013Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12124000	USD
CY2013Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	9231000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	16431000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	376000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	6824000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	90000	USD
CY2013Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	82000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	8000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-5292000	USD
CY2013Q1	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-7000	USD
CY2013Q1	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	354000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	4955000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	643000	USD
CY2014Q1	exas	Increase Decrease In Lease Incentive Payable IncreaseDecreaseInLeaseIncentivePayable	-135000	USD
CY2014Q1	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	8000	USD
CY2012	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	30534	shares
CY2013	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	32666	shares
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13345000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8053000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17806000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12351000	USD
CY2014Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	4926000	USD
CY2014Q1	exas	Interest Payable Noncurrent InterestPayableNoncurrent	90000	USD
CY2014Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	269000	USD
CY2014Q1	exas	Lease Incentive Payable Noncurrent LeaseIncentivePayableNoncurrent	1980000	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	713000	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	457776000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	125000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-336866000	USD
CY2014Q1	us-gaap	Licenses Revenue LicensesRevenue	294000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7430000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4586000	USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4456000	USD
CY2014Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	86000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70987000	shares
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	8000	USD
CY2014Q1	us-gaap	Depreciation Depreciation	656000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1995000	USD
CY2014Q1	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-294000	USD
CY2014Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	145000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	570000	USD
CY2014Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	6000	USD
CY2014Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2352000	USD
CY2014Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	24419000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4763000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	17304000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	88000	USD
CY2014Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	86000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2000	USD
CY2014Q1	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	456000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	133000	USD

Files In Submission

Name	View Source	Status
0001104659-14-034090-index-headers.html	Edgar Link	pending
0001104659-14-034090-index.html	Edgar Link	pending
0001104659-14-034090.txt	Edgar Link	pending
0001104659-14-034090-xbrl.zip	Edgar Link	pending
a14-9176_110q.htm	Edgar Link	pending
a14-9176_1ex31d1.htm	Edgar Link	pending
a14-9176_1ex31d2.htm	Edgar Link	pending
a14-9176_1ex32d1.htm	Edgar Link	pending
exas-20140331.xml	Edgar Link	completed
exas-20140331.xsd	Edgar Link	pending
exas-20140331_cal.xml	Edgar Link	unprocessable
exas-20140331_def.xml	Edgar Link	unprocessable
exas-20140331_lab.xml	Edgar Link	unprocessable
exas-20140331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2014 Q2 Form 10-Q Financial Statement

#000110465914034090 Filed on May 02, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2014 Q2 Form 10-Q Financial Statement

#000110465914034090 Filed on May 02, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas